Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-037-1 | CAS number: 65997-01-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation
The following information is taken into account for any hazard/risk assessment:
No sensitisation data are available for Tall Oil Soap therefore good quality data for the related substance Crude Tall Oil have been read across. Crude Tall Oil was found to be sensitising in a murine local lymph node assay (LLNA) carried out in accordance with OECD Test Guideline 429 and in compliance with GLP (Weber, 2005).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13.09.05 to 16.11.05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelman GmbH
- Age at study initiation: approximately 8 weeks
- Weight at study initiation: 16.4-21.6 g
- Housing: Individually in Makrolon Type II cages.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: Five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 (average)
- Humidity (%): 64.8 (average)
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 14.09.05 To: 19.09.05 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 10, 25 and 50 % (v/v) equivalent to doses of 15, 37.5 and 75 mg, respectively.
- No. of animals per dose:
- Five
- Details on study design:
- RANGE FINDING TESTS:
- Compound concentration: 100 and 50%
- Irritation: No local skin irritation with either dose. There was a slight increase in ear thickness at the highest dose, but not at the lower dose.
- Lymph node proliferation response: Not measured.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: if the test substance induces a three-fold or greater increase in 3HTdR incorporation into lymph node cells of test lymph nodes relative to that recorded for control lymph nodes, as indicated by the stimulation index, together with the consideration of dose response.
TREATMENT PREPARATION AND ADMINISTRATION: The test substance (25 µl/ear) was administered in three concentrations to the dorsal surfaces of the ears of the animals of the test substance groups. In a manner identical to that of animals in the treatment groups animals of one negative control group and one positive control group were treated with acetone/olive oil and hexyl cinnamic aldehyde, respectively. Each animal was treated for three consecutive days. Three days after the last administration the proliferation of the lymphocytes of the draining lymph nodes was measured by the determination of the amounts of incorporated 3HTdR (20 µCi of 3HTdR administered to mice via the tail vein).
Approximately 5 hours after 3HTdR injection all animals were sacrificed by carbon dioxide asphyxiation and the draining auricular lymph nodes were rapidly excised. The lymph nodes of each group were pooled in PBS. A single cell suspension (SCS) of lymph node cells (LNC) was prepared by gentle mechanical disaggregation of the pooled lymph nodes. The SCSs were then transferred into centrifuge tubes and LNC were pelleted by centrifugation. Afterwards supernatants were removed by aspiration. Then the LNC were resuspended and washed twice with PBS. After the final washing the supernatants were removed leaving just a small volume (<0.5 mL) and macromolecules were precipitated by incubation with 5 % trichloroacetic acid (TCA) at 4°C overnight. Each precipitate was pelleted by centrifugation and resuspended in 1 mL TCA. This suspension was transferred into scintillation vials containing 10 mL scintillation cocktail and 3HTdR incorporation was determined with a β-scintillation counter. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- No data
- Positive control results:
- Application of 25% HCA in AOO resulted in an SI of 5.3. This result proves the sensitivity of the strain of animals used and the reliability of the experimental technique.
- Key result
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- low dose group
- Key result
- Parameter:
- SI
- Value:
- 2.6
- Test group / Remarks:
- medium dose group
- Key result
- Parameter:
- SI
- Value:
- 2.9
- Test group / Remarks:
- high dose group
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- negative control group
- Key result
- Parameter:
- SI
- Value:
- 5.3
- Test group / Remarks:
- positive control group
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Low, medium and high dose: 4338, 13098 and 19314. Negative control: 4955 Positive control: 26402
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- In a good quality Local Lymph Node Assay (reliability score 1) conducted according to OECD test guideline 429, and GLP, Crude Tall Oil (CAS 8002-26-4) was regarded as a skin sensitiser. It is considered valid to read across this result to the related substance Tall Oil Soap.
- Executive summary:
Crude Tall Oil was diluted with acetone: olive oil (AOO), 4:1, v/v (10, 25 and 50% solutions) and was administered to three groups of five female CBA/Ca mice. Administration was performed epicutaneously to the dorsal surface of both ears, once per day on three consecutive days. The volume administered was 25 µl per ear. Positive (hexyl cinnamic aldehyde: HCA 25% in AOO) and negative (AOO) control substances were administered under identical conditions as the test substance. Five days after the first topical application, 3H-thymidine was intravenously administered to all mice via a tail vein. Approximately five hours later all animals were sacrificed, the draining auricular lymph nodes were excised, pooled for each group, and single cell suspensions were prepared. Then incorporation of 3H-methyl thymidine into the cells was determined and compared with the negative controls. The stimulation index (SI) was calculated as the ratio of the disintegrations per minute (DPM) of the dosed groups or of the positive control group to the DPM of the negative control group.
All animals survived until the end of the study, and no adverse effects were observed in any of the animals. Body mass gains were within the normal range for the strain, sex and age of the mice used. No skin irritating effects were observed in any of the groups. The SIs of the test substance were 0.9, 2.6 and 3.9 for the low, medium and high dose groups, respectively. The positive control group gave a SI of 5.3, thus demonstrating the validity of the test. According to the OECD test guideline a positive result should be regarded if the SI is equal to or greater than 3, together with consideration of the dose-response. Therefore it was concluded by the authors that Crude Tall Oil is sensitising to the skin.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
No sensitisation data are available for Tall Oil Soap, therefore, good quality data for the related substance Tall Oil have been read across. Crude Tall Oil was found to be sensitising in a murine local lymph node assay (LLNA) carried out in accordance with OECD Test Guideline 429 and in compliance with GLP (Weber, 2005). The stimulation indices of the test substance were 0.9, 2.6 and 3.9 for the low, medium and high dose groups, respectively. The positive control group gave a SI of 5.3, thus demonstrating the validity of the test. According to the OECD test guideline a positive result should be regarded if the SI is equal to or greater than 3, together with consideration of the dose-response. A concentration-dependent response was observed, therefore it was concluded by the authors that Tall Oil is sensitising to the skin.
Read-across justification:
Crude Tall Oil (CTO) is a UVCB substance comprising over eighty constituents, broadly described as fatty acids, rosin acids and neutrals. CTO is obtained from the neutralisation of Tall Oil Soap (TOS). TOS is obtained as a by-product from the Kraft Pulping process but contains the monosodium salts of the fatty acids and rosin acids, rather than the free acid. Since these are weak acids, and CTO has been shown in reliable, guideline studies to be non-corrosive and non-irritant, the toxicological behaviour of the sodium salts in vivo will be identical to that of the free acid constituents, because they will dissociate to the corresponding acid and Na+. Sodium is a ubiquitous, essential element in nature and will not contribute to the toxicology of Tall Oil Soap.
The sensitisation potential of abietic acid, breakdown products and other substances relevant to Tall Oil Distillates, which are also constituents of TOS was reviewed by the “Maximale Arbeitzplatz-Konzentration” (maximum workplace concentration) (MAK, 2013). The constituents included:15-hydroperoxyabietic acid methylester; 15-hydroperoxyabietic acid; 15-hydroperoxydehydroabietic acid methylester; 15-hydroperoxydehydroabietic acid; 7-oxodehydroabietic acid; abietic acid; abietyl alcohol; dehydroabietic acid; di(dehydroabietic acid-15-yl)peroxide; dihydroabietic acid; dismutated rosin; hydrated abietic acid; isopimaric acids; levopimaric acid; neoabietic acid; palustric acid; primaric acid; rosin acids; rosin;tetrahydroabietic acid; α-13,14-epoxyabietic acid methylester; α-epoxyabietic acid; β-13,14-epoxyabietic acid methylester; β-epoxyabietic acid (MAK, 2013).
Some of the human data gave conflicting results; however, the overall conclusion is potential for slight sensitisation for purified abietic acid. Some particular interesting results from the review study by MAK (2013) include that humans with pre-existing allergy to gum rosin had high positive sensitisation response to 15-hydroperoxyabietic acid which was also observed in animals. Similarly, 15-hydroperoxyabietic acid methylester in small concentrations was a significant sensitiser to animals. Moreover, subjects with pre-existing allergies towards plastics and adhesives had high proportion of positive sensitisation responses to abietic acid and rosin. Furthermore, MAK (2013) conclude that abietic acid does not stimulate an immune response i.e. is not an allergen itself, however, when becoming metabolised into an immunologically reactive form or is in the form of one of the oxidation products, abietic acid is a potent sensitiser in humans as well as in animals.
The data reviewed is summarised in the tables below. The information included skin sensitisation results obtained from human data following patch test, case reports as well as in vitro/in vivo animal data.
Since TOS contains 10-40% rosin acid sodium salts (typical ca. 23%), and typically approximately 10% by weight of sodium abietate, the positive animal and human sensitisation data for these constituent types support the conclusion that TOS would be expected to exhibit skin sensitising potential.
Table : Sensitisation potential of rosin and abietic acid and its derivatives in humans having contact dermatitis
Substance tested:
Already known allergy/sensitisation towards:
Total number of subjects:
Sensitisation reaction:
Percentage of positive reaction (%):
Reference cited:[1]
Abietic acid
Native/modified rosin
41
26
63
Geier & Hausen, 2000
Rosin
n/a
5755
156
2.7
Scheuer et al., 1992
Abietic acid
n/a
4246
29
0.7
Scheuer et al., 1992
Abietic acid
Plastics and adhesives
142
2
1.4
Kanerva et al., 1997
Abietic acid
Plastics & adhesive
343
3 (of clinical relevance)
0.9
Tarvainen, 1995
Rosin
Plastics & adhesive
8
8
100
Tarvainen, 1995
7-oxodehydroabietic acid (purified)
Rosin
20
20
100
Sadhra et al., 1996, 1997
Abietic acid (95 %)
Rosin (unmodified)
35
21
60
Sadhra et al., 1996
Abietic acid (99 %)
Rosin (unmodified)
35
19
54
Sadhra et al., 1996
Dehydroabietic acid
Rosin (unmodified)
35
0
0.0
Sadhra et al., 1996
Levopimaric acid
Rosin (unmodified)
35
6
17
Sadhra et al., 1996
Palustric acid
Rosin (unmodified)
35
5
14
Sadhra et al., 1996
Neoabietic acid
Rosin (unmodified)
35
3
8.6
Sadhra et al., 1996
Pimaric acid
Rosin (unmodified)
35
2
5.7
Sadhra et al., 1996
Isopimaric acid
Rosin (unmodified)
35
0
0.0
Sadhra et al., 1996
Rosin
Rosin (unmodified)
35
32
91
Sadhra et al., 1996
Rosin acid
Rosin (unmodified)
16
10
63
Sadhra & Foulds, 1995
Abietic acid (20%)
Rosin (unmodified)
16
12
75
Sadhra & Foulds, 1995
15-hydroperoxyabietic acid
Gum rosin
24
17
71
Karlberg & Gafvert, 1996
15-hydroperoxyabietic acid
Gum rosin
44
25
57
Karlberg & Gafvert, 1996
α-epoxyabietic acid
Gum rosin
12
1
8.3
Karlberg & Gafvert, 1996
α-epoxyabietic acid
Gum rosin
12
3
25
Karlberg & Gafvert, 1996
β-epoxyabietic acid
Gum rosin
12
2
17
Karlberg & Gafvert, 1996
β-epoxyabietic acid
Gum rosin
12
5
42
Karlberg & Gafvert, 1996
7-oxodehydroabietic acid
Gum rosin
11
6
55
Karlberg & Gafvert, 1996
7-oxodehydroabietic acid
Gum rosin
11
8
73
Karlberg & Gafvert, 1996
15-hydroperoxydehydroabietic acid
Gum rosin
10
0
0.0
Karlberg & Gafvert, 1996
Di(dehydroabietic acid-15-yl)peroxide
Gum rosin
7
0
0.0
Karlberg & Gafvert, 1996
Abietic acid
(Moderate contact allergy to) rosin
14
7
50
Soderberg et al., 1990
Neoabietic acid
(Moderate contact allergy to) rosin
14
3
21
Soderberg et al., 1990
Dehydroabietic acid
(Moderate contact allergy to) rosin
14
0
0.0
Soderberg et al., 1990
Isopimaric acid
(Moderate contact allergy to) rosin
14
0
0.0
Soderberg et al., 1990
Levopimaric acid
(Moderate contact allergy to) rosin
14
0
0.0
Soderberg et al., 1990
Abietic acid
Contact dermatitis
390
9
2.3
Wahlberg, 1978
Rosin
Contact dermatitis
390
15
3.8
Wahlberg, 1978
Abietic acid
Contact dermatitis
45
3 (also positive to 20% colophony in ethanol)
6.7
Wikstrom, 1969
Rosin
Contact dermatitis
45
10
4.5
Wikstrom, 1969
Table : Sensitisation potential of rosin, abietic acid and its derivatives in humans in case reports
Substance tested:
Already known allergy/sensitisation towards: Sensitisation reaction:
Percentage of positive reaction (%): Total number of subjects:
Reference cited:[1] Abietic acid
Colophonium allergy
Test: 13
Control: 11
11
0
85
0
Karlberg et al., 1991
Abietic acid
Rosin
10
0
0.0
Karlberg et al., 1985
Rosin
Rosin
13
13
100
Foussereau et al., 1980
Abietic acid
Rosin
13
7
54
Foussereau et al., 1980
Dihydroabietic acid
Rosin
12
3
25
Foussereau et al., 1980
Dehydroabietic acid
Rosin
10
4
40
Foussereau et al., 1980
Tetrahydroabietic acid
Rosin
11
1
9.0
Foussereau et al., 1980
Hydrated abietic acid
Rosin
9
2
20
Foussereau et al., 1980
Abietyl alcohol
Rosin
12
9
75
Foussereau et al., 1980
Dismutated Rosin (disproportionated rosin)
Rosin
11
2
18
Foussereau et al., 1980
Table : Sensitisation potential of abietic acid and its derivatives in animals
Substance tested:
Total number of subjects:
Sensitisation reaction:
Percentage of positive reaction (%):
Reference cited:[1]
Abietic acid (non-purified)
Test: 20
Following challenge with rosin: 20
1
8
5
40
Karlberg et al., 1980
Abietic acid (99.8 %) purity
20
0
0
Karlberg et al., 1985
7-oxodehydroabietic acid
20
4
20
Karlberg et al., 1988b
7-oxodehydroabietic acid
Test (1 %): 20
Test (5%): 20
Petrolatum: 20
Control: 20
4
8
11
1
20
40
55
5
Karlberg et al., 1988b
Abietic acid (1 %)
10
4
40
Hausen et al., 1989
Abietic acid (10 %)
10
4
40
Hausen et al., 1989
Abietic acid methylester (1 %)
Abietic acid methylester (10 %)
10
10
5
10
50
100
Hausen et al., 1989
Dehydroabietic acid (1 %)
Dehydroabietic acid (5 %)
Dehydroabietic acid (10 %)
10
10
10
0
2
0
0
20
0
Hausen et al., 1989
Isopimaric acid (in the form of piperidine salt)
10
0
0
Hausen et al., 1989
Levopimaric acid in the form of salt (1 %)
Levopimaric acid in the form of salt (5 %)
Levopimaric acid in the form of salt (10 %)
10
10
10
3
7
6
30
70
60
Hausen et al., 1989
Neoabietic acid in the form of piperidine salt (1 %)
Neoabietic acid in the form of piperidine salt (5 %)
Neoabietic acid in the form of piperidine salt (10 %)
8
8
8
0
1
2
0
13
25
Hausen et al., 1989
Tetrahydroabietic acid (1 %)
Tetrahydroabietic acid (10 %)
10
10
3
5
30
50
Hausen et al., 1989
Palustric acid
10
4
40
Hausen & Hessling, 1990
Pimaric acid
10
0
0
Hausen & Hessling, 1990
Sandaracopimaric acid
10
1
10
Hausen & Hessling, 1990
13,14-epoxyabietic acid
10
6
60
Hausen & Hesslinh, 1990
15-hydroxydehydroabietic acid
10
0
0
Hausen et al., 1990
7-oxodehydroabietic acid (3 %)
7-oxodehydroxyabietic acid (10 %)
10
10
4
8
40
80
Hausen et al., 1990
α-13,14-epoxyabietic acid methylester (1 %)
α-13,14-epoxyabietic acid methylester (5 %)
15
15
13
15
86
100
Gafvert et al., (unknown year)
β-13,14-epoxyabietic acid methylester (0.2 %)
β-13,14-epoxyabietic acid methylester (1 %)
β-13,14-epoxyabietic acid methylester (5 %)
15
15
15
2
14
15
13
93
100
Gafvert et al., (unknown year)
15-hydroperoxyabietic acid
10
10
100
Gafvert et al., 1992
15-hydroperoxyabietic acid methylester (1 %)
15-hydroperoxyabietic acid methylester (5 %)
11
11
8
7
72
63
Karlberg et al., (unknown year)
15-hydroperoxydehydroabietic acid methylester (1 %)
15-hydroperoxydehydroabietic acid methylester (5 %)
15
15
13
14
86
93
Shao et al., 1995
[1]All references are cited in full in MAK, 2013.
Reference:
DFG, Deutsche Forschungsgeimenschaft. (2013).The MAK-Collection Part 1, MAK Value Documentations 2013.Wiley-VCH Verlag GmbH & Co. KGaA.
Justification for classification or non-classification
Several independent toxicologists have reviewed the available LLNA study with a view to whether Crude Tall Oil should be classified for skin and respiratory sensitisation based on these results. Their findings can be found in the following references: Mallett, A.K., (2006) A Regulatory Assessment of the Skin and Respiratory Sensitisation Potential of Crude Tall Oil. & Illing, P., (2005) Evaluation of Draft report 'Crude Tall Oil Skin Sensitisation Study (LLNA). The reviewers came to different conclusions regarding the need to classify, mainly due to the apparent weak skin sensitising potential of Crude Tall Oil. Illing (2005) concluded that since the criteria for classification do not differentiate between weak and moderate/strong sensitisers, Crude Tall Oil would probably require classification. However, this would be precautionary. Mallett (2006) noted that since most skin sensitisers are not respiratory sensitisers in humans, automatic classification of Crude Tall Oil as a respiratory sensitiser would be highly precautionary; the registrants do not consider that this classification is warranted.
On the basis of a reliable (reliability 1) murine local lymph node assay (LLNA) that was carried out in accordance with OECD Test Guideline 429 and in compliance with GLP with the related substance Crude Tall Oil (CTO), Tall Oil Soap is classified as Skin Sens. Cat.1B (H317: May cause an allergic skin reaction) in accordance with Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.